Home » Astex Pharmaceuticals to Present AT26893 at EASL
Astex Pharmaceuticals to Present AT26893 at EASL
Astex Pharmaceuticals announced it will present data on AT26893, a novel, first-in-class, direct acting antiviral agent against Hepatitis C Virus at the 47th Annual Meeting of the European Association for the Study of the Liver (EASL).
MarketWatch
MarketWatch
Upcoming Events
-
07May
-
14May
-
30May